AstraZeneca To Buy Neogene Therapeutics For Up To $320 Mln

LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) said that it agreed to buy all outstanding equity of Neogene Therapeutics for a total consideration of up to $320 million, on a cash and debt free

Related Keywords

California ,United States ,Netherlands ,London ,City Of ,United Kingdom ,Amsterdam ,Noord Holland , ,Astrazeneca ,Astrazeneca Plc ,Neogene Therapeutics ,Neogene ,Herapeutics ,